GL1X · GenesisL1 explorer

Research workbench

HTLV-1 protease in complex with the HIV-1 protease inhibitor indinavir

Analyse HTLV-1 protease in complex with the HIV-1 protease inhibitor indinavir in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3WSJ
Type
protein
Length
232 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
UniProt
Q82134
Ligands
MK1, SO4
Pockets
2 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 8% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProteaseprotein1168% helix, 40% strandQ82134

Ligands and binding sites

  • MK1 · N-[2(R)-hydroxy-1(S)-indanyl]-5-[(2(S)-tertiary butylaminocarbonyl)-4(3-pyridylmethyl)piperazino]-4(S)-hydroxy-2(R)-phenylmethylpentanamide · ligand · chains A, B
  • SO4 · Sulfate ion · ion · 13 copies · chains A, B
  • PG4 · Tetraethylene glycol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15630.720.8040MK1
2760.350.7617SO4

Interfaces

1 interface between chains.

  • A–B · 2000 Ų buried · 38 hydrogen bonds · protein-protein

Compared structures

  • 3WSJ · HTLV-1 protease in complex with the HIV-1 protease inhibitor Indinavir · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.